Giovanni Farinea - Dissemin

Language
Login

All papers authored by Giovanni Farinea

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2024 Francesco Passiglia, Luisella Righi, Paolo Bironzo, Angela Listì, Giovanni Farinea

ORCID

, Enrica Capelletto, Silvia Novello, Alessandra Merlini, Giorgio V. Scagliotti

Supplementary Figure 1 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Francesco Passiglia, Luisella Righi, Paolo Bironzo, Angela Listì, Giovanni Farinea

ORCID

, Enrica Capelletto, Silvia Novello, Alessandra Merlini, Giorgio V. Scagliotti

Data from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Francesco Passiglia, Luisella Righi, Paolo Bironzo, Angela Listì, Giovanni Farinea

ORCID

, Enrica Capelletto, Silvia Novello, Alessandra Merlini, Giorgio V. Scagliotti

Supplementary Figure 2 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Francesco Passiglia, Luisella Righi, Paolo Bironzo, Angela Listì, Giovanni Farinea

ORCID

, Enrica Capelletto, Silvia Novello, Alessandra Merlini, Giorgio V. Scagliotti

Supplementary Table 2 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Francesco Passiglia, Luisella Righi, Paolo Bironzo, Angela Listì, Giovanni Farinea

ORCID

, Enrica Capelletto, Silvia Novello, Alessandra Merlini, Giorgio V. Scagliotti

Supplementary Table 1 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Francesco Passiglia, Luisella Righi, Paolo Bironzo, Angela Listì, Giovanni Farinea

ORCID

, Enrica Capelletto, Silvia Novello, Alessandra Merlini, Giorgio V. Scagliotti

Supplementary Figure 3 from Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

This paper is made freely available by the publisher.

2023 Mariangela Calabrese, Isabella Saporita, Fabio Turco

ORCID

, Silke Gillessen, Elena Castro

ORCID

, Ursula Maria Vogl

ORCID

, Rosario Francesco Di Stefano, Federica Maria Carfì, Stefano Poletto

ORCID

, Giovanni Farinea

ORCID

, Marcello Tucci, Consuelo Buttigliero

ORCID

Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

Francesco Passiglia

ORCID

, Luisella Righi

ORCID

, Paolo Bironzo

ORCID

, Angela Listì

ORCID

, Giovanni Farinea

ORCID

, Enrica Capelletto

ORCID

, Silvia Novello

ORCID

, Alessandra Merlini

ORCID

, Giorgio V. Scagliotti

ORCID

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial

Upload

Missing publications? Search for publications with a matching author name.